In my opinion, although the topic is very relevant in light of the correlation of calpain overactivation during development and neuropsychiatric disorders in adult stage , yet seems to be far away from the real publication stage. In order to achieve that the authors need an overall and thorough revision of the article. My specific comments are as follows ·When exactly MWM training get started? There should be proper spacing between anxiety test and memory test. All animals gone through the same tests or different group of animals for each tests? My main concern is swimming is also a known stressor and improper plan may give wrong result.
·It looks like more than two groups were there like calpeptin group has sub groups as P7, P8, P 14 & p60, only 't' test cannot be justified. ANOVA is recommended for evaluating real NEURAL REGENERATION RESERACH www.nrronline.org effects with appropriate posthoc analysis. ·Under result section, (Postnatal administration of calpeptin attenuated SCOP-Akt pathway) the comments are contradictory. In 5th line the author says "Total Akt, mTor, as well as p-Akt and p-mTor were not different between two groups in the adult animals".In 12th line, " compared with control group, the expressive level of p-Akt after calpeptin injection was significantly reduced (P<0.05),"... ·Regarding spine density statement, specific marker neurabin expression should have been also included as well, for clarity.
